default author photo

Cuiyan Yang

Shanghai Jiao Tong University (SJTU) - Rui-Jin Hospital

SCHOLARLY PAPERS

2

DOWNLOADS

130

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Can HER2-Low Tumor Be Considered as a Biologically Distinct Subtype with HER2-Zero Tumor in Triple-Negative Breast Cancer: Comparison Clinical Characteristics, Gene Mutation Spectrums, Gene Expression Levels, and Prognosis

Number of pages: 31 Posted: 01 Aug 2022
Shanghai Jiao Tong University (SJTU) - Rui-Jin Hospital, Shanghai Jiao Tong University (SJTU) - Rui-Jin Hospital, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Rui-Jin Hospital, Shanghai Jiao Tong University (SJTU) - Department of Pathology, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Department of Pathology, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center and Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center
Downloads 68 (891,180)

Abstract:

Loading...

Triple-negative breast cancer, HER2-low, Genomic profiling, Transcriptomic profiling, Prognosis

2.

Associaction between Prognosis, Carboplatin Treatmene Response and Homologous Recombination Deficiency Status in Early Triple-Negative Breast Cancer

Number of pages: 26 Posted: 20 Nov 2023
Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Department of Pathology, Shanghai Jiao Tong University (SJTU) - Department of Pathology, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Rui-Jin Hospital, Amoy Diagnostics Co., Ltd. - Department of Translational Oncology, Amoy Diagnostics Co., Ltd. - Department of Translational Oncology, Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center, Shanghai Jiao Tong University (SJTU) - Department of Pathology and Shanghai Jiao Tong University (SJTU) - Comprehensive Breast Health Center
Downloads 62 (942,565)

Abstract:

Loading...

triple negative breast cancer, homologous recombination deficiency, clinicopathological factors, pathological response, prognosis